Parkinson's Disease: Biochemistry, Clinical Pathology, and Treatment |
Contents
Biochemistry | 6 |
The Clinical Pathology of Parkinsons Disease | 46 |
Treatment | 89 |
Copyright | |
3 other sections not shown
Common terms and phrases
activity administration akinesia akinetic crises amantadine anticholinergic antidepressant autonomic basal behaviour benserazide biochemical biogenic amine Birkmayer and Riederer brain regions brain stem bromocriptine catecholamine caudate nucleus cells choline cholinergic clinical concentrations controls correlate cortex decarboxylase inhibitor decrease deficit degeneration deprenyl depression disability score disorders disturbances dopa dopamine agonists dopaminergic dopaminergic neurons dosage enzyme extrapyramidal feedback GABA GABA-T Hornykiewicz human brain hyperkinesia improvement increase inhibition investigations Jellinger L-dopa L-dopa dose L-dopa therapy L-dopa treatment lesions lisuride loss Madopar MAO inhibitors McGeer medication metabolism metabolites mg L-dopa monoamine oxidase motor function movement Nagatsu Neural Transm neuroleptics Neurology neurons neurotransmitters nigro-striatal nomifensine noradrenaline noradrenergic normal Number of patients occur pallidus Parkinson's disease parkinsonian patients parkinsonian symptoms pathway peripheral Plasma post-mortem postsynaptic presynaptic psychosis putamen reduced release reserpine rigidity serotonergic serotonin side effects Sinemet stimulation striatal striatum substantia nigra syndrome Table therapeutic transmitter tranylcypromine tremor tryptophan tyrosine hydroxylase Yahr